The Human LAG3 / CD4 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between T-cell surface glycoprotein CD4 and its receptor lymphocyte activation gene 3 protein in the presence of potential inhibitors within 4 hours. 4-8 week development phase.
Form:
96-well Microplate
Samples:
Plasma, Serum, Antibodies, Proteins, Small Molecules, Peptides
Target:
CD4, LAG-3 (LAG3)
Application Notes:
Colorimetric
* VAT and and shipping costs not included. Errors and price changes excepted
